期刊文献+

血液透析联合血液灌流治疗尿毒症顽固性高血压 被引量:6

在线阅读 下载PDF
导出
摘要 目的:血液透析联合血液灌流治疗尿毒症顽固性高血压的疗效。方法:将26例尿毒症顽固性高血压患者随机分为两组,A组采用HD-HP联合治疗,B组采用HD治疗。结果:两组患者血压均有下降,但A组患者下降明显,最有统计学意义。结论:HD+HP治疗尿毒症顽固性高血压效果显著,值得临床推广。
出处 《医学信息(中旬刊)》 2011年第8期3580-3580,共1页 Medical Information Operations Sciences Fascicule
  • 相关文献

参考文献3

二级参考文献19

  • 1[1]Mikhalovsky SV. emerging technologies in extracorporeal treatment:focus on adsorption. Perfusion, 2003,18(7) :47 - 54
  • 2[2]Vanholder R. Review on uremic toxins: Classification, concentration,and interindividual variability. Kidney International,2003,63(5): 1934- 1943
  • 3[3]James F. Removal of Middle Molecules with Sorbents. Artif Cells Blood Substit Immobil Biotechnol, 2002,30(5- 6):547- 554
  • 4[4]Clark WR. Middle molecules and small- molecular- weight protiens in ESRD: Properties and strategies for their removal. Adv Ren Replace Ther,2003, 10(4) :270 - 278
  • 5[5]Morena MD. Effect of novel adsorbent on cytokine responsiveness to uremic plasma. Kidney Int,2003,63(3):1150-4
  • 6[6]Winchester JF. The next step from high - flux dialysis: application of sorbent technology. Blood Purif, 2002,20(1):81-6
  • 7[7]Vanholder R. Survival of hemodialysis patients uremic toxin removal.Artifi Organ,2003,27 (7) :218 - 23
  • 8[9]Schlaeper C. High clearance continuious renal replacement therapy with a modified dialysis machine. Kidney Int Suppl, 1999,72(56): S20 - 3
  • 9[10]Lesaffer G. Comparative kinetics of the uremic toxin p - cresol versus creatinine in rats with and without renal failure. Kidney Int, 2003, 64(4): 1365 - 73
  • 10[11]Fagugli RM. Behavior of non - protein- bound and protein- bound uremic solutes during daily hemodialysis. Am J Kidney Dis, 2002,40(2) :339 - 47

共引文献146

同被引文献28

  • 1杨秀芹,孙玉兰.血液透析加血液灌流治疗尿毒症顽固性高血压[J].中国血液净化,2004,3(8):462-462. 被引量:77
  • 2卢方平.尿毒症中分子毒素与血液灌流[J].国际移植与血液净化杂志,2006,4(1):8-11. 被引量:40
  • 3彭小梅,龚智峰,闭闵,伍秋霞,张文欣,吴潮清.血液透析-灌流串联治疗尿毒症血透患者顽固性高血压的观察[J].广西医学,2006,28(2):194-196. 被引量:26
  • 4王质刚.血液净化学[M].3 版.北京:科学技术出版社,2010:857-867.
  • 5James F.Removal of Middle molecules with sorbbents[J].Artif Cells Blood Substit Immobil Biotechnol,2002,30(5-6):547-554.
  • 6Whitworth JA.Progression of renal failure the role of hypertension[J].Ann Acad Med Sing,2005,34(1):8-15.
  • 7Morena MD.Effect of novel adsorbent on cytokine responsiveness to uremic plasma[J].Kidney Int,2003,63(3):1150-1154.
  • 8Cui HW,Song XY,Yang HJ,et al.uremic dialysis patients;doublerenal extirpation resulting in intractable hypotension in a case withnursing experience of[C].Third National severe liver diseases,artificial liver and blood purification Academic Annual Conference(the first volume),2007.
  • 9James F.Removal of Middle molecules with sorbbents[J].ArtifCellsBlood Substit Immobil Biotechnol,2002,30(5-6):547-554.
  • 10Whitworth JA.Progression of renal failure the role ofhypertension[J].Ann Acad Med Sing,2005,34(1):8-15.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部